These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19013836)

  • 1. [Prescription drug atlas 2008--prescription drug utilization in the German national health insurance. The sick patient as a business machine].
    Aumiller J
    MMW Fortschr Med; 2008 Oct; 150(41):7. PubMed ID: 19013836
    [No Abstract]   [Full Text] [Related]  

  • 2. [Impact of potentially inappropriate drug usage on health insurance business results].
    Kirschke M; Böhme J
    Versicherungsmedizin; 2014 Sep; 66(3):142-5. PubMed ID: 25272660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistics and drug utilization: are prescribing rates really that high?
    Morgan S
    CMAJ; 2001 Nov; 165(11):1507-8. PubMed ID: 11762577
    [No Abstract]   [Full Text] [Related]  

  • 4. Questioning patient subgroups for benefit assessment: challenging the German Gemeinsamer Bundesausschuss approach.
    Ruof J; Dintsios CM; Schwartz FW
    Value Health; 2014 Jun; 17(4):307-9. PubMed ID: 24968988
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cost reducing of or by drugs. More rationality and efficiency in drug therapy].
    Glaeske G
    Internist (Berl); 2010 Aug; 51(8):1057-60, 1062-3. PubMed ID: 20552155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug atlas corrects political reproaches: why drug expenditures of GKV are really increasing].
    Schmidt K
    MMW Fortschr Med; 2007 Mar; 149(9):50-1. PubMed ID: 17612254
    [No Abstract]   [Full Text] [Related]  

  • 7. [Regress for expensive medicines? When costly therapies are not a problem].
    Nitz G
    MMW Fortschr Med; 2013 Feb; 155(3):12. PubMed ID: 23573755
    [No Abstract]   [Full Text] [Related]  

  • 8. Election 2015: new arguments for pharmacare.
    Vogel L
    CMAJ; 2015 Nov; 187(17):E483-E484. PubMed ID: 26464142
    [No Abstract]   [Full Text] [Related]  

  • 9. [Medication prices in Germany--how are they determined?].
    Bruhn C
    Dtsch Med Wochenschr; 2010 Oct; 135(39):p34. PubMed ID: 20922657
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic catastrophes: exploring the concentration and sustained nature of ambulatory prescription drug expenditures in the population of British Columbia, Canada.
    Hanley GE; Morgan S
    Soc Sci Med; 2009 Mar; 68(5):919-24. PubMed ID: 19135288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors Affecting Usage Levels and Trends of Innovative Oncology Drugs Upon and After Reimbursement Under Taiwan National Health Insurance: Interrupted Time Series Analysis.
    Liao KH; Ko BS; Chen LK; Hsiao FY
    Clin Transl Sci; 2020 Nov; 13(6):1288-1297. PubMed ID: 32583962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Medication supply of privately insured patients in 2010].
    Wild F
    Versicherungsmedizin; 2012 Jun; 64(2):85-6. PubMed ID: 22808648
    [No Abstract]   [Full Text] [Related]  

  • 13. Prescription drug use continues to increase: U.S. prescription drug data for 2007-2008.
    Gu Q; Dillon CF; Burt VL
    NCHS Data Brief; 2010 Sep; (42):1-8. PubMed ID: 20854747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiologies reflect on cost cuts. Waste with heart drugs?].
    Schumacher B
    MMW Fortschr Med; 2003 Sep; 145(38):4-5. PubMed ID: 14603669
    [No Abstract]   [Full Text] [Related]  

  • 15. Share Of Specialty Drugs In Commercial Plans Nearly Quadrupled, 2003-14.
    Dusetzina SB
    Health Aff (Millwood); 2016 Jul; 35(7):1241-6. PubMed ID: 27385240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription drug accessibility and affordability in the United States and abroad.
    Morgan S; Kennedy J
    Issue Brief (Commonw Fund); 2010 Jun; 89():1-12. PubMed ID: 20614652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evolution of consumption of high-cost drugs in Colombia].
    Machado Alba JE; Moncada Escobar JC
    Rev Panam Salud Publica; 2012 Apr; 31(4):283-9. PubMed ID: 22652967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should national pharmacare apply a value-based insurance design?
    Yeung K; Morgan SG
    CMAJ; 2019 Jul; 191(29):E811-E815. PubMed ID: 31332049
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of copayments and generic substitution on the use and costs of prescription drugs.
    Smith DG
    Inquiry; 1993; 30(2):189-98. PubMed ID: 8314607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Scope of the contract for drug therapy. Rebate contracts also for original drugs].
    MMW Fortschr Med; 2009 Jul; 151(30-33):80. PubMed ID: 19722473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.